SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001193125-05-044688
Filing Date
2005-03-08
Accepted
2005-03-08 16:58:07
Documents
9
Period of Report
2004-12-31

Document Format Files

Seq Description Document Type Size
1 FOR THE FISCAL YEAR ENDED DECEMBER 31, 2004 d10k.htm 10-K 1060370
2 AMENDED AND RESTATED CERTIFICATE OF INCORPORATION OF THE REGISTRANT dex31a.htm EX-3.1A 17869
3 AMENDED AND RESTATED BYLAWS OF THE REGISTRANT dex32a.htm EX-3.2A 158346
4 COMPUTATION RATIO OF EARNINGS AVAILABLE TO COVER FIXED CHARGES dex121.htm EX-12.1 28646
5 LIST OF SUBSIDIARIES dex211.htm EX-21.1 4520
6 CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM dex231.htm EX-23.1 2243
7 SECTION 302 CEO CERTIFICATION dex311.htm EX-31.1 9352
8 SECTION 302 CFO CERTIFICATION dex312.htm EX-31.2 9376
9 SECTION 906 CEO AND CFO CERTIFICATION dex32.htm EX-32 5000
  Complete submission text file 0001193125-05-044688.txt   1298311
Mailing Address
Business Address 420 CHIPETA WAY STE 240 SALT LAKE CITY UT 84108-1256 8015834939
NPS PHARMACEUTICALS INC (Filer) CIK: 0000890465 (see all company filings)

IRS No.: 870439579 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 000-23272 | Film No.: 05667287
SIC: 2836 Biological Products, (No Diagnostic Substances)